These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 426520)

  • 1. BL-S786 (ceforanide), a new parenteral cephalosporin: in vitro studies.
    Weaver SS; LeBlanc BM; Bodey GP
    Antimicrob Agents Chemother; 1979 Feb; 15(2):318-22. PubMed ID: 426520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity and beta-lactamase stability of BL-S786 compared with those of other cephalosporins.
    Aswapokee N; Aswapokee P; Fu KP; Neu HC
    Antimicrob Agents Chemother; 1978 Jul; 14(1):1-5. PubMed ID: 686701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporins.
    Jones RN; Thornsberry C; Barry AL; Fuchs PC; Gavin TL; Gerlach EH
    J Antibiot (Tokyo); 1977 Jul; 30(7):583-92. PubMed ID: 893227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model.
    Randolph JA; Buck RE; Price KE; Leitner F
    J Antibiot (Tokyo); 1979 Jul; 32(7):727-33. PubMed ID: 396292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of a new parenteral cephalosporin--HR 756: comparison with cefamandole and ceforanide.
    Counts GW; Turck M
    Antimicrob Agents Chemother; 1979 Jul; 16(1):64-8. PubMed ID: 112919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro studies of cefamandole.
    Bodey GP; Weaver S
    Antimicrob Agents Chemother; 1976 Mar; 9(3):452-7. PubMed ID: 769679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo studies with BL-S786, cefoxitin, and cefamandole.
    Shadomy S; Wagner G; Carver M
    Antimicrob Agents Chemother; 1978 Mar; 13(3):412-5. PubMed ID: 400821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolates.
    Jones RN; Fuchs PC; Gavan TL; Gerlach EH; Barry A; Thornsberry C
    J Antibiot (Tokyo); 1977 Jul; 30(7):576-82. PubMed ID: 893226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of cefamandole in vitro.
    Meyers BR; Hirschman SZ
    J Infect Dis; 1978 May; 137 Suppl():S25-S31. PubMed ID: 349095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of LY127935, a new 1-oxa cephalosporin, against aerobic gram-negative bacilli.
    Delgado DG; Brau CJ; Cobbs CG; Dismukes WE
    Antimicrob Agents Chemother; 1979 Dec; 16(6):864-8. PubMed ID: 533267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
    Nishino T; Otsuki M; Hatano K; Nishihara Y
    Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefamandole: antimicrobial activity in vitro of a new cephalosporin.
    Meyers BR; Leng B; Hirschman SZ
    Antimicrob Agents Chemother; 1975 Dec; 8(6):737-41. PubMed ID: 1044248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro study in new cephalosporins.
    Bodey GP; Fainstein V; Hinkle AM
    Antimicrob Agents Chemother; 1981 Aug; 20(2):226-30. PubMed ID: 7283419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of LY127935.
    Fass RJ
    Antimicrob Agents Chemother; 1979 Oct; 16(4):503-9. PubMed ID: 518080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of cefmenoxime (SCE-1365).
    Stamm JM; Girolami RL; Shipkowitz NL; Bower RR
    Antimicrob Agents Chemother; 1981 Mar; 19(3):454-60. PubMed ID: 6264846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceforanide: antibacterial activity, pharmacology, and clinical efficacy.
    Barriere SL; Mills J
    Pharmacotherapy; 1982; 2(6):322-7. PubMed ID: 6762529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antimicrobial activity of cefotaxime, a new cephalosporin.
    Masuyoshi S; Arai S; Miyamoto M; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Jul; 18(1):1-8. PubMed ID: 6251749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic.
    Shemonsky NK; Carrizosa J; Levison ME
    Antimicrob Agents Chemother; 1975 Dec; 8(6):679-83. PubMed ID: 1211920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftezole, a new cephalosporin C derivative I. In vitro and in vivo antimicrobial activity.
    Noto T; Nehashi T; Endo H; Saito M; Matsubara S
    J Antibiot (Tokyo); 1976 Oct; 29(10):1058-70. PubMed ID: 994325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antibacterial activity of FK041, a new orally active cephalosporin.
    Watanabe Y; Hatano K; Matsumoto Y; Tawara S; Yamamoto H; Kawabata K; Takasugi H; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1999 Jul; 52(7):649-59. PubMed ID: 10513845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.